Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition.
Journal: Molecular cancer therapeutics
Published: April 04, 2017
Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors.
Journal: Molecular cancer research : MCR
Published: August 24, 2016
DNA-PkCS expression in oropharyngeal squamous cell carcinoma: Correlations with human papillomavirus status and recurrence after transoral robotic surgery.
Journal: Head & neck
Published: July 05, 2016
Combining Chk1/2 Inhibition with Cetuximab and Radiation Enhances In Vitro and In Vivo Cytotoxicity in Head and Neck Squamous Cell Carcinoma.
Journal: Molecular cancer therapeutics
Published: June 01, 2016
MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines.
Journal: Oncology letters
Published: April 08, 2016
Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Journal: Molecular cancer research : MCR
Published: April 05, 2016
Gene Expression Profiling of Advanced Penile Squamous Cell Carcinoma Receiving Cisplatin-based Chemotherapy Improves Prognostication and Identifies Potential Therapeutic Targets.
Journal: European urology focus
Published: March 21, 2016
Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.
Journal: PloS one
Published: March 15, 2016
The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathways.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: July 04, 2014
HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair.
Journal: Cancer research
Published: September 19, 2012
Last Updated: 09/26/2026